Neurotransmitter Agents - Therapeutic use
Research News and Information

Sunday, November 22, 2009

Animal models of narcolepsy.

30 Jul 2009 Narcolepsy is a debilitating sleep disorder with excessive daytime sleepiness and cataplexy as its two major symptoms. Although this disease was first described about one century ago, an animal model was not available until the 1970s. With the ... Read more...

Restless legs syndrome: diagnostic time-savers, Tx tips.

30 Jul 2009 To diagnose restless legs syndrome (RLS), start with the 4 "essential criteria": (1) a powerful urge to move the legs that is (2) rest-induced, (3) improves with activity, and (4) worsens in the evening. Carefully screen for secondary causes of RLS, ... Read more...

Organic electronics for precise delivery of neurotransmitters to modulate mammalian sensory function.

3 Jul 2009 Significant advances have been made in the understanding of the pathophysiology, molecular targets and therapies for the treatment of a variety of nervous-system disorders. Particular therapies involve electrical sensing and stimulation of neural ... Read more...

Latest indexed articles for 'Neurotransmitter Agents - Therapeutic use'

These are the very latest articles for this heading:

• Animal models of narcolepsy. 30 Jul 2009
• Restless legs syndrome: diagnostic time-savers, Tx tips. 30 Jul 2009
• Organic electronics for precise delivery of neurotransmitters to modulate mammalian sensory function. 3 Jul 2009
• [The role of the neuromodulators in the preventive treatment of migraine] 29 Jun 2009
• Neuromodulation in patients deployed to war zones. 29 Jun 2009
• Depression and antidepressants: molecular and cellular aspects. 10 Jun 2009
• Emerging therapies for sleep disorders. 30 May 2009
• Fibromyalgia--pathways and neurotransmitters. 30 May 2009
• Current strategies in the diagnosis and treatment of childhood attention-deficit/hyperactivity disorder. 13 Apr 2009
• Efficacy of treatments for patients with obsessive-compulsive disorder: a systematic review. 30 Mar 2009
• Oral self-injurious behaviors in patients with developmental disabilities. 30 Mar 2009
• [Impulse regulation disturbances. Physiopathology and treatment] 5 Feb 2009
• Botulinum toxin type a (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction. Feb 2009
• Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults. 30 Dec 2008
• Critical commentary 3: steroid dysregulation and stomatodynia (burning mouth syndrome). 30 Dec 2008
• Intraventricular orexin-A improves arousal and early EEG entropy in rats after cardiac arrest. 14 Dec 2008
• Does analysis using "last observation carried forward" introduce bias in dementia research? 5 Oct 2008
• Neuromodulators for the treatment of headache disorders and fibromyalgia. 29 Sep 2008
• Disrupting nicotine reinforcement: from cigarette to brain. 29 Sep 2008
• The pharmacological management of intermittent priapismic states. 10 Sep 2008

See a longer list of these articles.

Technical information about 'Neurotransmitter Agents'

Definition: Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function.

Registry Number: 0

Descriptor UI: D018377

Alternative terms: Neurotransmitter Agents; Agents, Neurotransmitter; Neuromodulators; Neuromodulator; Neurohormones; Neurotransmitters; Transmitter Substances, Nerve; Substances, Nerve Transmitter; Nerve Transmitter Substances; Neurotransmitter; Neurohumors; Neuroregulators; Neuroregulator;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.519.625; D27.505.696.577;

History Note: 1998; use explode 1995-1997

Technical Notes: general; prefer specifics